Dietary heme iron is an important nutritional source of iron in carnivores and omnivores that is more readily absorbed than non-heme iron derived from vegetables and grain. Most heme is absorbed in the proximal intestine, with absorptive capacity decreasing distally. We utilized a subtractive hybridization approach to isolate a heme transporter from duodenum by taking advantage of the intestinal gradient for heme absorption. Here we show a membrane protein named HCP1 (heme carrier protein 1), with homology to bacterial metal-tetracycline transporters, mediates heme uptake by cells in a temperature-dependent and saturable manner. HCP1 mRNA was highly expressed in duodenum and regulated by hypoxia. HCP1 protein was iron regulated and localized to the brush-border membrane of duodenal enterocytes in iron deficiency. Our data indicate that HCP1 is the long-sought intestinal heme transporter.
Introduction
Iron is essential for nearly all forms of life. In humans, anemia due to iron deficiency affects millions of people worldwide. On the other hand, iron overload due to genetic diseases such as hemochromatosis, in which too much iron is taken up from the diet, is also a serious health risk. Iron can be absorbed from the diet in two forms: as inorganic (non-heme) iron predominantly released from foods such as vegetables or cereals, or as heme iron from the breakdown of hemoglobin and myoglobin contained in red meat. Heme (ferrous protoporphyrin IX) is more efficiently absorbed than inorganic iron from the diet, and the iron released as a result of cleavage of the porphyrin ring makes a significant contribution to body iron stores (Lynch et al., 1989) . For convenience, we use the term heme here to indicate iron-protophorphyrin IX irrespective of the oxidation state of the iron.
Bacteria have developed several strategies to capture heme and utilize the iron contained within the porphyrin ring. These include direct binding of heme and hemoglobin to outer membrane receptors as well as capture of hemoglobin and hemopexin via secreted proteins (reviewed in Genco and Dixon [2001] ). In mammals, the duodenal enterocytes and hepatocytes are major sites of heme transport, although the mechanism by which heme is transported across the plasma membranes in these cells has remained elusive (Uzel and Conrad, 1998; Muller-Eberhard, 1988; Smith and Morgan, 1984) . Although it has been shown that heme can diffuse across model lipid membranes due to its hydrophobic nature (Light and Olson, 1990) , studies in isolated hepatocytes (Noyer et al., 1998) As with the absorption of inorganic iron, the epithelial cells of the duodenal mucosa play a key role in dietary heme absorption and have the highest capacity to take up heme compared to other regions such as ileum, which has the lowest absorptive capacity for heme absorption (Wheby et al., 1970) . We utilized a subtractive hybridization approach to isolate a heme transporter from duodenum by taking advantage of the intestinal gradient for heme absorption. Here, we describe the properties and regulation of a putative intestinal heme transporter (HCP1).
Results

HCP1 Encodes a Protein with Homology to Bacterial
Tetracycline-Resistance Proteins HCP1 was isolated from mouse duodenum using suppression subtractive hybridisation (Diatchenko et al., 1996) . A similar approach has led to the identification of two other proteins involved in the intestinal absorption of non-heme iron, ferroportin, and Dcytb (Figure 1A) . This homology may, in part, be due to similarities in the structures of heme and the metal tetracycline complex ( Figure 1B ).
HCP1 Mediates Heme Uptake
To determine whether HCP1 was capable of heme transport, we expressed the protein in Xenopus oocytes and measured heme uptake at RT (20°C) and 4°C using 55 Fe-heme liganded with either L-arginine or BSA. In oocytes injected with HCP1 cRNA, we observed a 2.5-fold increase (p < 0.0001) in 55 Fe-heme uptake at 20°C compared to water-injected controls when L-arginine was used as the ligand ( Figure 2F ). When BSA was substituted as the heme donor, total uptake was reduced approximately 10-fold but remained significantly (p = 0.01) above control (data not shown). These results indicated that both heme-arginine and heme-BSA were able to donate heme for uptake via HCP1. In experiments conducted at 4°C, 55 Feheme uptake by oocytes expressing HCP1 was greatly reduced, indicative of an energy-dependent process (data not shown). Varying the pH of the uptake buffer from 6.5 to 8.5 had no significant effect on heme uptake into oocytes (data not shown).
We next investigated the properties of 55 Fe-heme uptake in cultured HeLa cells infected or not with HCP1 adenovirus. Due to the apparent toxicity of the HCP1 adenovirus to HeLa cells (see far right panel, Figure 3A ), we were unable to use high virus titres for uptake experiments. We found that using a relatively low virus titre resulting in 5%-10% infection of cells measured by antibody staining (panel marked by an arrow in Figure 3A) was sufficient to observe a consistent 2-to 3-fold increase in heme transport above background without significantly affecting cell viability. A time course of 55 Fe-heme uptake was performed in both uninfected and HCP1-infected HeLa cells at 37°C and 4°C ( Figure 2A ) using a heme concentration of 2.0 M. In HCP1-infected cells, uptake of 55 Fe-heme was significantly increased (4.5 × 10 −5 < p < 0.04) at all time points after 5 min (Figure 2A ). There was an initial steep increase in 55 Fe-heme uptake in both HCP1 infected and control uninfected cells, which appeared to reach a plateau after 20 min. At 4°C, uptake was greatly reduced in both uninfected and virally transduced cells. Transport of heme by HCP1 virally transduced cells appeared to be linear over a wide range of heme concentrations and was significantly higher (0.0003 < p < 0.04) than uninfected cells at all concentrations of heme (Figure 2B) . Subtraction of the endogenous uptake from the HCP1-induced uptake revealed a saturable component with an apparent Vmax app of 3.1 pmol/min/g protein and Km app of 125 M heme ( Figure 2C) .
To address the specificity of HCP1, we measured uptake of 3 H-tetracycline and 59 Fe (III) in comparison to 55 Fe-heme HCP1 infected cells and uninfected cells ( Figure 2D ). We found that, in contrast to the 2-fold increase in heme uptake (p < 0.001), there was no increase in either 3 H-tetracycline or 59 Fe(III) transport in HCP1 infected cells, providing additional evidence that HCP1 was specific for heme. In addition, we found that a 100× excess cold heme, ZnPP (zinc protoporphyrin) or PP (protoporphyrin IX), decreased HCP1-dependent uptake to values indistinguishable from endogenous uptake ( Figure 2E ). To show that HCP1 mediated transmembrane transport of heme, we utilized the fluorescent analog of heme, ZnPP, and measured uptake in CHO cells transfected with HCP1. There was much stronger fluorescence in HCP1-transfected cells than in control, indicating greater uptake of ZnPP ( Figure 2E,  inset) .
Transfection of the CHO cells stably expressing an HCP1-GFP fusion with an HCP1-specific siRNA abolished the HCP1-induced increase in 55 Fe-heme uptake ( Figure 4A ). Confocal image analysis revealed that the specific RNAi but not the scrambled oligo markedly reduced the HCP1-GFP signal (by FACS analysis, the decrease in GFP signal was reduced approximately 2-fold, data not shown). The scrambled siRNA oligo itself had no effect on heme uptake in untransfected cells, which was the same as the no-oligo control (data not shown). We conclude that HCP1 is capable of mediating transmembrane uptake of heme in a temperature-dependent and saturable manner and, moreover, that the transporter is specific for the porphyrin ring since uptake was competed by both ZnPP and PP.
To investigate whether the HCP1 antibody could functionally block intestinal heme transport, we measured 55 Fe-heme uptake in vitro using everted duodenal sacs taken from normal and hypoxic mice in the presence of the HCP1 antibody or preimmune serum. In normal mice, 55 Fe-heme uptake was 1.94 ± 0.33 pmol/mg tissue in everted sacs incubated with preimmune sera; however, in the presence of the HCP1 antisera, uptake was significantly (p = 0.02) decreased to 1.33 ± 0.18 pmol/mg tissue. In hypoxic mice, in the presence of preimmune sera, 55 Fe-heme uptake was 3.21 ± 1.25 pmol/mg tissue. This was reduced to 1.95 ± 0.51 pmol/mg tissue in the presence of the HCP1 antibody (p = 0.037). These data strongly suggest HCP1 plays a direct role in intestinal heme uptake.
Regulation of HCP1 mRNA and Protein in Mouse
Intestine by Iron, Hypoxia, and Hypotransferrinaemia We screened various mouse tissues for expression of the HCP1 transcript by Northern blotting. High expression was found in duodenum with low expression detected in the kidney ( Figure 5A ). No expression was seen in mouse duodenum before weaning or in placenta ( Figure 5A ). Using more sensitive RNase protec- Figure S2 ). In hypotransferrinemic (trf hpx/hpx ) mice, there was a small increase in duodenal mRNA content in mutant mice compared with wild-type mice ( Figure  5C , compare +/− with −/−). Q-PCR performed on mRNA from duodenum of three homozygotes compared to three heterozygotes also revealed a small increase, which did not reach statistical significance (p = 0.08, data not shown). Exposure of mice to hypoxia for 3 days is known to induce iron absorption (Raja et al., 1988) and reduce levels of the iron-regulatory peptide hepcidin in the liver (Nicolas et al., 2002) . We found that hypoxia produced a marked induction in HCP1 mRNA levels in duodenum ( Figure 5B ). We have found that exposure to hypoxia does significantly stimulate duodenal uptake of 59 Fe-heme in vivo compared to normal mice (48.6 ± 5.1 normal versus hypoxic 66.7 ± 7.2 nmol heme/mg wt/10 min; SD, p < 0.03). We conclude that HCP1 mRNA is strongly regulated by hypoxia but appears less sensitive to changes in iron stores compared with genes involved in transport of non-heme iron.
In control mice, the HCP1 protein was localized both in the apical membrane as well as in the cytoplasm ( Figure 6A ). However, in iron-deficient mice, there was a striking localization of the protein at the brush-border membrane with little or no cytoplasmic staining evident ( Figure 6A ). In contrast, in iron-loaded mice, no apical staining was evident and the protein appeared to accumulate in the cytoplasm of the cell ( Figure 6A ).
High doses of oral iron given to iron-deficient rats have been shown to downregulate both mRNA and protein levels of DMT1 and Dcytb in the duodenum 12-16 hr after administration (Frazer et investigate whether HCP1 protein was regulated by high doses of oral iron, we dosed iron-deficient mice by gavaging (introducing iron directly into the stomach by a rounded syringe) with iron and performed immunostaining on duodenal sections obtained at 0, 3, 16, and 72 hr after the dose was given (Figure 7) . At time zero, HCP1 appeared highly localized at the brush-border membrane. After 3 hr, HCP1 staining was slightly reduced, but there was still strong apical staining of HCP1. After 16 hr, there was no evidence of HCP1 protein on the apical membrane, with most staining appearing in the cytoplasm (Figure 7 ). This time point correlated with the highest liver non-heme iron values. After the iron dose was given (72 hr) there was a recovery of HCP1 protein levels in apical membrane ( Figure  7) . We conclude that HCP1 protein subcellular localization is regulated by a posttranslational mechanism in response to changes in iron stores.
To confirm that HCP1 was localized to the brush border, we performed immunoelectron microscopy with colloidal gold using the HCP1 antibody. Sections of duodenum stained with HCP1 antibody revealed the presence of gold particles in the brush-border membrane and in the apical cytoplasm ( Figure 6B, right panel) . In contrast, no gold particles were detected on the sections incubated with preimmune sera (left panel, Figure 6B ).
Discussion
Our results identify HCP1 as an intestinal heme transporter capable of mediating energy-dependent, trans- ., 1999) . However, alignment of HCP1 sequence from different species did reveal four fully conserved His residues that could act as heme ligands ( Figure 1C) . We did not detect a recognizable iron response element (IRE) in either 5# or 3# UTRs of the HCP1 cDNA sequence.
HCP1 displayed relatively high homology to bacterial tetracycline transporters. A particularly highly conserved motif, GXXSDRXGRR, present between TM2 and TM3 is found in all metal-tetracycline transporters and in all HCP1 sequences from five species ( Figure  1C, circled amino 
acids). The motif is also found in other multi-drug-resistance transporters and protonassociated sugar transporters within the MFS, and mutation of either Gly residue in tetracycline resistance proteins abolishes metal-tetracycline transport function (Yamaguchi et al., 1992). This motif is also present in the recently described protein FLVCR, involved in heme efflux in erythroid precursor cells (Quigley et al., 2004).
In gram-negative bacteria, primary resistance to tetracycline is based on active efflux of a metal-tetracycline complex in exchange for a proton (Yamaguchi et (Ditchburn and Pritchard, 1956 ) with the metal in the center (depicted in Figure 1B) . It is interesting to note the similarities in structure of a metal [tetracycline] 2 complex, the likely substrate for the resistance proteins, and that of heme ( Figure 1B) . The molecular weight of heme is 645.7, compared to 978.9 for a tetracycline iron complex, and both molecules are predominantly planar hydrophobic structures, each possessing one hydrophilic edge.
Expression of HCP1 mRNA was found at several sites of known heme transport, notably the duodenum and the liver, with weak expression in kidney. In the circulation, any free heme resulting from hemolysis is rapidly bound by the serum proteins hemopexin and albumin, whereas free hemoglobin is bound by haptoglobin. These complexes are rapidly cleared in the liver by distinct mechanisms. Hemoglobin-haptoglobin uptake takes place in macrophages expressing the CD163 receptor (Kristiansen et al., 2001 ). Heme-hemopexin complexes interact with the plasma membrane of the hepatocyte by a mechanism that has not been fully characterized involving uptake of the heme and release of the free hemopexin (Smith and Morgan, 1981) . A third mechanism involving a heme transporter expressed in hepatocytes capable of transport of heme bound to albumin has also been described (Noyer et al., 1998) . We did not measure HCP1-mediated heme uptake from the heme-hemopexin complex, but we did observe uptake of heme from heme-BSA complexes. It is possible that HCP1 could play an additional physiological role in the liver by clearance of heme bound to plasma albumin. In kidney, it has been suggested that filtered hemoglobin may be reabsorbed in the proximal tubule to prevent iron loss and as an antibacterial mechanism, by a process involving binding of hemoglobin to megalin and cubilin receptors (Gburek et al., 2002) . Our data would suggest that HCP1 expression in kidney may also play a role in scavenging any free heme.
Iron stores, hypoxia, and rate of erythropoesis are well-known stimulators of dietary inorganic iron absorption; however, less is known about their effects on heme absorption. Studies in human subjects have shown that the magnitude of change in intestinal heme absorption in response to changes in iron stores is less than for inorganic iron absorption (Turnbull et al., 1962; Lynch et al., 1989) . In rats, some investigators have found no effect of iron deficiency on duodenal heme uptake, while others have found 2-to 3-fold and 10-fold increases ( . In the present study, we found no significant increases in HCP1 mRNA in response to either iron deficiency or increased ineffective erythropoesis (hpx mice), but we did observe regulation of HCP1 protein at the brush-border (apical) membrane. The HCP1 protein shifted from the apical membrane to the cytoplasm of the duodenal enterocyte in response to changes in iron stores induced either by high doses of dietary iron or systemic iron loading, in a similar manner to proteins involved in non-heme iron transport. This suggests that iron stores may regulate intestinal heme transport via posttranslational regulation of HCP1 protein. The nature of this regulatory mechanism has yet to be fully understood; however, the recent demonstration that iron-regulatory peptide hepcidin binds to the ferroportin protein, causing its internalization and degradation (Nemeth et al., 2004b) , is important. This would lead to increased intracellular iron levels, which may be the trigger for a cascade of events resulting in changes in the subcellular localization of iron transporters in the enterocyte. The recovery of HCP1 staining in the apical membrane of iron-deficient mice 72 hr after giving the oral iron is consistent with the time required for clearance of the iron and formation of new enterocytes and was also observed with DMT1 and Dcytb proteins (Frazer et al., 2003) . We found that hypoxia had a significant effect on HCP1 mRNA levels and on heme iron absorption in vivo. We are unable to say whether increased HCP1 mRNA in response to hypoxia was due to a direct effect of hypoxia on HCP1 transcription, as there were no detectable HIF-1 elements within the promoter sequence of HCP1. The identification of HCP1 provides the long-soughtafter mechanism by which heme iron can be acquired from the diet. It is likely that mutations in the HCP1 gene would alter the ability of the gut to absorb dietary heme iron and, therefore, would be an important determinant of iron stores, particularly in iron overload diseases such as hereditary hemochromatosis. The common form of hereditary hemochromotosis (HFE C282Y) is known to have a low penetrance, and, therefore, polymorphisms in genes like HCP1 could affect the manifestation of the disease. Little is known about the mechanism of transport of free heme across cell membranes, notably the mitochondrial membrane; hence, the identification of HCP1 and related proteins may have wider implications for heme transport in other tissues and organelles.
Conclusions
We have identified an iron-regulated intestinal heme transporter. The HCP1 protein sequence shares homology with bacterial tetracycline efflux transporters, a fact that may be related to the similarities in structure of the substrates transported. HCP1-mediated heme uptake was temperature dependent, saturable, and abolished by HCP1-specific siRNA and did not transport either free iron or tetracycline. Moreover, duodenal heme uptake was inhibited by incubation with HCP1 antisera, indicating that HCP1 is directly involved in intestinal heme transport. Results using temperature shifts and ZnPP indicated that HCP1-mediated heme uptake represented transport of heme into the cell. HCP1 mRNA was highly expressed in duodenal mucosa and appeared not to be iron regulated but was induced by hypoxia. The subcellular localization of HCP1 protein within the duodenal enterocyte was markedly influenced by iron status and in iron deficiency was localized at the apical membrane, whereas iron loading resulted in movement of the protein to the cytoplasm.
Experimental Procedures
Cloning of HCP1 To isolate HCP1, tfr hpx/hpx mice were used, since these mice have a highly increased rate of erythropoesis (Huggenvik et al., 1989) , low levels of circulating hepcidin (Weinstein et al., 2002) , and, consequently, a very high rate of iron absorption (McKie et al., 2000) . Although heme iron absorption has, to our knowledge, not been measured in these mice, we assumed that this would also be upregulated. Since heme absorption is highest in the duodenum and much lower in ileum (Wheby et al., 1970) , we subtracted ileal cDNA from duodenal cDNA in a homozygote mouse. The subtracted cDNA library was constructed using PCR-Select (BD Biosciences) as previously described (McKie et al., 2000) . Briefly, target (tester) cDNA was synthesized from duodenum of a tfr hpx/hpx mouse. Nontarget (driver) cDNA was synthesized from the ileum of the same mouse. The subtracted library was cloned into a TA vector (Invitrogen). Expression of library clones was validated by Northern blot analysis. Using this approach, a 245 bp fragment of HCP1 (original clone name DI9 for duodenum-ileum clone 9) was isolated. Full-length cDNAs of both murine and human HCP1 (gi 34786034 and 31543204, respectively) were found by conducting a BLAST search with this sequence against the GenBank database.
Northern Blotting and RT-PCR
Total RNA was extracted from tissues and Northern blotting was carried out as previously described (McKie et al., 1996) . The mouse cell line mRNA blot was obtained from Clontech BD Biosciences. A PCR product of the full-length HCP1 cDNA was used as a probe. Iron status of these mice was confirmed by measuring liver nonheme iron levels and by probing the same blot with probe for transferrin receptor, whose mRNA was strongly upregulated in iron deficiency and downregulated in iron loading (McKie et al., 1996) . Quantitative RT-PCR was carried out using an ABI Prisim 7000 detection system using a one-step RT-PCR protocol with Sybr green (ABI). Results were standardized using 18 s ribosomal RNA and β-actin. 
Electron Microscopy
Duodenal samples were fixed in 4% formaldehyde in 0.1 M PIPES buffer, infiltrated with 2.3 M sucrose and cryofixed in liquid nitrogen. Cryosections 70 nm thick were cut using an RMC CRX cryoultramicrotome and collected using the Tokuyasu technique (Tokuyasu, 1986). Thawed sections were incubated for 1 hr with primary rabbit antibody, washed, and then incubated with 10 nm gold-conjugated antiserum (Aurion, The Netherlands). The sections were mounted in a mixture of methyl cellulose and uranyl acetate (nine parts 2% methyl cellulose: 1 part 3% aqueous uranyl acetate). Examination was performed using a JEOL 1200 electron microscope.
Alterations in Iron Status in Mice
Male mice (6-to 9-week-old) of the CD-1 and genetic strains were used for experimental manipulations of iron status as previously described (McKie et al., 2000) . Oral gavaging was carried out by dosing mice with 200 g iron as ferrous sulfate made up in water. Liver non-heme iron values were carried out by TCA extraction of iron from liver samples and the iron level determined spectrophotometrically as previously described (McKie et al., 2000) . Fe citrate and housed in a metabolic cage for 1 week. The animal was bled and the red cells washed three times in 10 volumes of saline and then lysed in 10 volumes of distilled water. Heme was then isolated from the hemoglobin by crystallization using the method of Labbe and Nishada (Labbe and Nishida, 1957) . In situ tied-off duodenal segments were used to determine intestinal heme iron absorption as described (Raja et al., 1987) . Animal procedures were approved by the UK Home Office.
Antibody Blocking Experiments using Everted Duodenal Segments
Mice exposed to normoxia or 3 days hypoxic (0.5 atm in a hypobaric chamber) were anaesthetized and the duodenum removed (the first 10 cm of the small intestine distal to the bile duct opening). Following the removal and clearance of any connective tissues and mesenteries, the intestinal segment was washed with ice-cold 0.15 M sodium chloride and then inverted longitudinally so as to expose the mucosal surface. Two tied-off loops were made from each segment by closing the two end parts. After rinsing in 1 ml of oxygenated physiological medium (125 mM NaCl, 3.5 mM KCl, 1 mM CaCl 2 , 10 mM MgSO 4 , 10 mM D-glucose in 16mM HEPESNaOH buffer [pH 7.4]), the loops were incubated at 37°C in oxygenated physiological medium containing (0.5C as 55 Fe-heme) as a heme arginate (10 M) with either preimmune serum as a control or HCP1 antisera at a dilution of 1:100 added to the incubation medium. After 10 min incubation, the uptake was terminated by rinsing the tissue in ice-cold Hank's solution (Sigma) and then three times in 1% BSA for 1 min each. These rinses are optimal for removal of the maximum adherent heme without loosing of intracellular radioactivity. After reblotting and weighing, the tissue were solublized, and radioactivity was assayed in the tissue and in 10 l aliquots of the incubating medium using a twin channel β counter (LKB Wallac-1209). The results were expressed as pmol/mg wet tissue.
Statistical Analysis
Data are presented as means ± SEM or SD where indicated. Groups were compared using Student's t test. Nonlinear regression analysis ( Figure 2C ) was performed using Sigma Plot using a onesite saturation ligand binding curve (equation, y = VmaxX/Kd + X).
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